Translational hurdles in anti-asthmatic nanomedicine development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Translational hurdles in anti-asthmatic nanomedicine development

Published:2024-07-02 Issue:7 Volume:21 Page:987-989
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Akram Muhammad Waseem¹²,Wong Tin Wui¹²³

Affiliation:

1. Non-Destructive Biomedical and Pharmaceutical Research Centre, Smart Manufacturing Research Institute, Universiti Teknologi MARA Selangor, Puncak Alam, Malaysia

2. Particle Design Research Group, Faculty of Pharmacy, Universiti Teknologi MARA Selangor, Puncak Alam, Selangor, Malaysia

3. Sino-Malaysia Molecular Oncology and Traditional Chinese Medicine Delivery Joint Research Centre, Medical College, Yangzhou University, Yangzhou, China

Funder

Ministry of Higher Education

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2024.2385092

Reference19 articles.

1. Pharmacological Strategies and Recent Advancement in Nano-Drug Delivery for Targeting Asthma

2. Small airways in asthma: From inflammation and pathophysiology to treatment response

3. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes

4. Mesoporous silica nanoparticles for pulmonary drug delivery

5. Emerging trends in inhaled drug delivery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP